A detailed history of Israel Englander (Millennium Management LLC) transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 392,608 shares of ZNTL stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
392,608
Previous 246,322 59.39%
Holding current value
$1.51 Million
Previous $3.88 Million 58.66%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.09 - $16.13 $598,309 - $2.36 Million
146,286 Added 59.39%
392,608 $1.61 Million
Q1 2024

May 15, 2024

BUY
$10.83 - $16.49 $2.34 Million - $3.56 Million
215,627 Added 702.48%
246,322 $3.88 Million
Q4 2023

Feb 14, 2024

SELL
$9.84 - $20.13 $1.55 Million - $3.17 Million
-157,625 Reduced 83.7%
30,695 $465,000
Q2 2023

Aug 14, 2023

BUY
$17.41 - $30.05 $2.77 Million - $4.78 Million
158,926 Added 540.67%
188,320 $5.31 Million
Q1 2023

May 15, 2023

SELL
$16.14 - $24.94 $45,062 - $69,632
-2,792 Reduced 8.67%
29,394 $506,000
Q4 2022

Feb 14, 2023

SELL
$18.07 - $25.6 $1.24 Million - $1.75 Million
-68,486 Reduced 68.03%
32,186 $648,000
Q3 2022

Nov 14, 2022

BUY
$20.23 - $31.73 $2.04 Million - $3.19 Million
100,672 New
100,672 $2.18 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $219M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.